Paion Ag (FRA:PA8) Stock Based Compensation : €0.05 Mil (TTM As of Jun. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Paion Ag Stock Based Compensation?

Paion Ag's Stock Based Compensation for the six months ended in Jun. 2023 was €0.01 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was €0.05 Mil.

Paion Ag Stock Based Compensation Historical Data

The historical data trend for Paion Ag's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paion Ag Stock Based Compensation Chart

Paion Ag Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Stock Based Compensation

Get a 7-Day Free Trial

0.40

0.33

0.29

0.34

0.13

Paion Ag Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Stock Based Compensation	Get a 7-Day Free Trial															0.16	0.18	0.09	0.04	0.01

Paion Ag Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.05 Mil.

Paion Ag Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Paion Ag's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Paion Ag (FRA:PA8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (FRA:PA8) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

PAIOF:USA

Address

Heussstrasse 25, Aachen, DEU, 52078

Website

https://www.paion.com

Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.

Paion Ag (FRA:PA8) Headlines

No Headlines